Alerts will be sent to your verified email
Verify EmailBIOGEN
|
Biogen Pharmachem
|
Contil India
|
Ushdev International
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.85 % | 13.0 % | 0.63 % |
|
5yr average Equity Multiplier
|
1.01 | 1.26 | -0.04 |
|
5yr Average Asset Turnover Ratio
|
0.02 | 2.1 | 0.12 |
|
5yr Avg Net Profit Margin
|
-19.83 % | 4.85 % | -131.68 % |
|
Price to Book
|
0.35 | 2.53 | 0.0 |
|
P/E
|
40.41 | 15.12 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 97.77 Days | 135.38 Days |
|
Inventory Days
|
0.0 | 19.16 Days | 0.0 |
|
Days Receivable
|
0.0 | 108.51 Days | 135.38 Days |
|
Days Payable
|
3.0 Days | 25.42 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
902.8 | 291.41 | -145.66 |
|
5yr Avg ROCE
|
0.2 % | 17.34 % | 0.55 % |
|
5yr Avg Operating Profit Margin
|
-19.88 % | 3.15 % | -213.28 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | -0.79 |
|
5yr CAGR Net Profit
|
-28.94 % | 32.37 % | n/a |
|
5yr Average Return on Assets
|
0.19 % | 10.29 % | -14.56 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 41.58 % | 40.7 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 37.98 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Biogen Pharmachem
|
Contil India
|
Ushdev International
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|